Does VEDOLIZUMAB Cause Hepatitis b? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Hepatitis b have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.0% of all adverse event reports for VEDOLIZUMAB.
13
Reports of Hepatitis b with VEDOLIZUMAB
0.0%
of all VEDOLIZUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Hepatitis b From VEDOLIZUMAB?
Of the 13 reports, 2 (15.4%) required hospitalization.
Is Hepatitis b Listed in the Official Label?
Yes, Hepatitis b is listed as a known adverse reaction in the official FDA drug label for VEDOLIZUMAB.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Hepatitis b?
RITUXIMAB (597)
CYCLOPHOSPHAMIDE (578)
LAMIVUDINE (480)
DOXORUBICIN (469)
VINCRISTINE (431)
PREDNISOLONE (371)
TENOFOVIR DISOPROXIL (257)
PREDNISONE (208)
DEXAMETHASONE (173)
ENTECAVIR (166)
Which VEDOLIZUMAB Alternatives Have Lower Hepatitis b Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB